Brooke Staggs, Orange County Register, March 19, 2021
The California Highway Patrol recently published its Impaired Driving Task Force report which gives recommendations on how to better track and test for drivers impaired by marijuana and other drugs. This article reviews some of the report's findings and recommendations.
The goal of the CMCR is to foster the careers of future generations of basic and clinical scientists who will help develop deeper understanding of the potentials of medical cannabis as well as the interactions of cannabis and cannabinoids on health and social and behavioral functioning. The Center addresses a broad range of areas in cannabinoid science, including the treatment of various medical and psychiatric conditions, pharmacology, animal models, and possible adverse effects (e.g., cognition, driving) of cannabis use. Details on the CMCR can be found at www.cmcr.ucsd.edu.
The scholar would work with CMCR leadership on projects advancing the mission of the Center and would be expected to ultimately develop his/her own grant submissions.
Previous research experience is desired. Selection criteria include the degree to which the applicant matches with the above-mentioned areas of interest.
Salary is based upon the NIH payscale and the candidate’s experience. Appointments are typically for one year with options to renew based on CMCR priorities and University policies.
Potential applicants who wish to learn more about the program may contact Dr. Tom Marcotte via email (
Citing the work of the Center for Medicinal Cannabis Research, Representative Scott Peters made remarks in support of the Medical Marijuana Research Act of 2019 (HR 3797) during a House Energy & Commerce Committee session in September 2020.
Rep. Peters discussed the importance of backing rigorous research to discover the full therapeutic potential of cannabis. He urged the committee to pass this bill as well as other legislation that includes Federal support for dedicated multidisciplinary medical cannabis research centers that could bolster evidence-based research on medical cannabis.
The Energy & Commerce Committee voted to advance the bill to the full House of Representatives for their consideration.
Scott LaFee, UC San Diego Health Newsroom, July 14, 2020
Researchers at UC San Diego's Center for Medicinal Cannabis Research (CMCR) are conducting a clinical trial to assess whether CBD can reduce behavioral symptoms of severe autism spectrum disorder.
Read the full press release here for more information
Study results show that cannabis appears cost-effective when augmenting second-line treatment for painful neuropathy.
Page 15 of 23